Xie et al. also showed that increased PES1 expression in CRC cells was associated with resistance to chemotherapeutic treatments (i.e., etoposide, 5-FU, doxorubicin, vincristine) and provided protection against DNA-induced damage [114]. The gene discussed is PES1; the disease is colorectal carcinoma.